Safety, tolerability, pharmacokinetics, and pharmacodynamics of an orally active novel camptothecin analog, DRF-1042, in refractory cancer patients in a phase I dose escalation study (Q44938157)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, tolerability, pharmacokinetics, and pharmacodynamics of an orally active novel camptothecin analog, DRF-1042, in refractory cancer patients in a phase I dose escalation study |
scientific article |
Statements
1 reference
Safety, tolerability, pharmacokinetics, and pharmacodynamics of an orally active novel camptothecin analog, DRF-1042, in refractory cancer patients in a phase I dose escalation study (English)
1 reference
Nuggehally R Srinivas
1 reference
Arani Chatterjee
1 reference
Raghunadharao Digumarti
1 reference
Rao N V S Mamidi
1 reference
Kasiram Katneni
1 reference
Vijay V Upreti
1 reference
Anjna Surath
1 reference
Maddali L Srinivas
1 reference
Srihari Uppalapati
1 reference
Sangeeta Jiwatani
1 reference
Swaminathan Subramaniam
1 reference
1 July 2004
1 reference
1 reference
44
1 reference
7
1 reference
723-736
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference